Please ensure Javascript is enabled for purposes of website accessibility

Is UiPath Stock a Buy Now?

By Eric Cuka – Sep 26, 2021 at 7:00AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

UiPath's stock has been under pressure since its recent earnings report. Is this an opportunity, or will the stock take another leg lower?

UiPath (PATH -9.09%) is one of many recent unicorns to IPO. The stock rallied to nearly $90 before crashing down after recent earnings. It's currently trading in the low $50s. Is it a buy now? Today, I'll dig into the company again, this time focused on the artificial intelligence side of its business. The below video continues my series on high-growth AI, where I have done my best to find the highest-growth companies in a variety of sectors with disruptive growth trends. Last time, I covered robotic surgery AI with Intuitive Surgical. Today, I'll discuss UiPath's AI and machine learning capabilities, as well as the current stock price. 

UiPath is a global software company focused on robotic process automation, also called RPA. The company's software enables organizations to automate data entry and repetitive tasks. RPA technology makes it simple for businesses to build, deploy, and manage bots. These software robots emulate human actions and provide many benefits. Examples include:

  • Increased production times
  • Reduction of costs
  • Increased employee creativity and innovation
  • Improved efficiency
  • Increased employee happiness and retention
  • Improved process quality 
  • Higher employee productivity
  • Improved customer service

UiPath's AI capabilities are robust in the following key areas, which I explain in more detail in the video:

  • AI computer vision 
  • AI Center 
  • Fully AI-enabled platform
  • Document understanding

UiPath is arguably the best pure-play stock in the RPA space, although it does face increasing competition from companies like Microsoft. With that said, UiPath is recognized by many as the clear robotic process automation leader, and customers have been increasing consumption once on the platform. UiPath's dollar-based net retention rate is 144%, which is phenomenal.

Gartner predicts that robotic process automation software revenues will be approximately $2 billion this year, which is up 20% year over year. Additionally, RPA revenues are estimated to grow at double-digit rates through the end of 2024. But UiPath's recent earnings report sent shares tumbling because of growth deceleration fears. The question you have as an investor is if the stock will bottom out around $50, or if the stock will go lower. 

Disruptive technology ETF ARK Innovation has been loading up on shares over the past several months, but should you? Is UiPath stock a buy now? Watch the below video for detailed analysis and due diligence on UiPath. I discuss its AI capabilities, growth prospects, and opinions on the share price. Please watch for more information, and don't forget to subscribe to the channel and take a look at the entire AI video series. 

*Stock prices used in the below video were during the trading day of September 24, 2021. The video was published on September 25, 2021.

Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool's board of directors. Eric Cuka owns shares of ARK Innovation ETF, Intuitive Surgical, Microsoft, Salesforce.com, Twilio, and UiPath Inc. The Motley Fool owns shares of and recommends Intuitive Surgical, Microsoft, Salesforce.com, Twilio, and UiPath Inc. The Motley Fool recommends Gartner and recommends the following options: long January 2022 $580 calls on Intuitive Surgical and short January 2022 $600 calls on Intuitive Surgical. The Motley Fool has a disclosure policyEric is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.

Stocks Mentioned

UiPath Stock Quote
UiPath
PATH
$13.21 (-9.09%) $-1.32
Microsoft Stock Quote
Microsoft
MSFT
$250.20 (-1.89%) $-4.82
Salesforce Stock Quote
Salesforce
CRM
$133.93 (-7.35%) $-10.63
Intuitive Surgical Stock Quote
Intuitive Surgical
ISRG
$269.72 (-0.93%) $-2.53
Gartner Stock Quote
Gartner
IT
$350.46 (-0.43%) $-1.53
Twilio Stock Quote
Twilio
TWLO
$46.09 (-5.24%) $-2.55
Ark ETF Trust - Ark Innovation ETF Stock Quote
Ark ETF Trust - Ark Innovation ETF
ARKK
$36.07 (-5.48%) $-2.09

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.